S.P. Park et al. / Tetrahedron 66 (2010) 3490–3498
3497
CH2), 7.37–7.51 (m, 3H, aromatic), 7.57 (t, J¼1.9 Hz, 1H, CH), 7.87–
7.90 (m, 2H, aromatic); 13C NMR (CDCl3)
26.1, 51.9, 125.9, 126.3,
128.7, 129.1, 130.1, 139.5, 140.8, 146.5, 192.9; EIMS: m/z (%) 199 (75),
184 (100), 156 (16), 106 (54); HRMS (FABþ): m/z C13H11N3ONa
[MþNa]þ calcd 248.0801, obsd 248.0800. Anal. Calcd for C13H11N3O:
C, 69.32; H, 4.92; N, 18.66. Found: C, 69.13; H, 5.04; N, 18.49.
CH3), 1.32–1.37 (m, 4H, two CH2), 1.67–1.77 (m, 2H, CH2), 2.29–2.37
(m, 2H, CH2), 2.58–2.63 (m, 2H, CH2), 2.80 (t, J¼7.7 Hz, 2H, CH2),
3.12–3.18 (m, 2H, CH2), 3.57 (dd, J¼2.7 and 2.5 Hz, 2H, CH2); 13C
d
NMR (CDCl3) d 14.0, 21.2, 22.2, 22.4, 24.4, 25.3, 28.1, 31.4, 37.3, 129.0,
136.6, 141.9, 152.9, 195.2; EIMS: m/z (%) 245 (2) [Mþ], 217 (56), 174
(100), 146 (21), 132 (11), 118 (16); HRMS (FABþ): m/z C14H19N3ONa
[MþNa]þ calcd 268.1428, obsd 268.1425. Anal. Calcd for C14H19N3O:
C, 68.54; H, 7.81; N, 17.13. Found: C, 68.25; H, 7.92; N, 16.95.
4.5.8. 5-Acetyl-3-(4-chlorophenyl)-6H-pyrrolo[1,2-c][1,2,3]triazole
(5h). Yield: 81%; white solid; mp: 195–196 ꢀC; IR (KBr) 1661 cmꢂ1; 1H
NMR (CDCl3)
(m, 2H, aromatic), 7.56 (t, J¼1.9 Hz, 1H, CH), 7.81–7.85 (m, 2H, aro-
matic); 13C NMR (CDCl3)
26.2, 52.0, 125.9, 127.1, 128.7, 129.3, 134.6,
139.6,139.8,146.8,192.8; EIMS: m/z(%) 235 (21), 233 (64), 220 (51), 218
(100), 192 (4), 190 (12), 106 (68); HRMS (FABþ): m/z C13H10ClN3ONa
[MþNa]þ calcd 282.0412, obsd 282.0411. Anal. Calcd for C13H10ClN3O:
C, 60.12; H, 3.88; N, 16.18. Found: C, 59.92; H, 3.69; N, 15.89.
d
2.55 (s, 3H, CH3), 5.17 (d, J¼1.9 Hz, 2H, CH2), 7.44–7.48
Acknowledgements
d
This work was supported in part by Brain Korea 21 program,
Republic of Korea.
References and notes
1. (a) Alvarez, R.; Velazquez, S.; San-Felix, A.; Aquaro, S.; De Clercq, E.; Perno, C. F.;
Karlsson, A.; Balzarini, J.; Camarasa, M. J. J. Med. Chem. 1994, 37, 4185–4194; (b)
Velazquez, S.; Alvarez, R.; Perez, C.; Gago, F.; De Clercq, E.; Balzarini, J.;
Camarasa, M. J. Antiviral Chem. Chemother. 1998, 9, 481–489.
2. Genin, M. J.; Allwine, D. A.; Anderson, D. J.; Barbachyn, M. R.; Emmert, D. E.;
Garmon, S. A.; Graber, D. R.; Grega, K. C.; Hester, J. B.; Hutchinson, D. K.; Morris,
J.; Reischer, R. J.; Ford, C. W.; Zurenko, G. E.; Hamel, J. C.; Schaadt, R. D.; Stapert,
D.; Yagi, B. H. J. Med. Chem. 2000, 43, 953–970.
3. Brockunier, L. L.; Parmee, E. R.; Ok, H. O.; Candelore, M. R.; Cascieri, M. A.;
Colwell, L. F., Jr.; Deng, L.; Feeney, W. P.; Forrest, M. J.; Hom, G. J.; MacIntyre, D.
E.; Tota, L.; Wyvratt, M. J.; Weber, A. E. Bioorg. Med. Chem. Lett. 2000, 10,
2111–2114.
4. Trybulski, E. J.; Benjamin, L.; Vitone, S.; Walser, A.; Fryer, R. I. J. Med. Chem. 1983,
26, 367–372.
5. (a) Fuks, R.; Viehe, H. G. In Chemistry of Acetylenes; Viehe, H. G., Ed.; Marcel
Dekker: New York, NY, 1969; pp 425–593; (b) Bastide, J.; Henri-Rousseau, O. In
The Chemistry of the Carbon-Carbon Triple Bond; Patai, S., Ed.; Interscience:
London, 1978; pp 447–522; (c) Padwa, A. In 1,3-Dipolar Cycloaddition Chemistry;
Taylor, E. C., Weissberger, A., Eds.; John Wiley: New York, NY, 1984; Vol. 2,
pp 277–386; (d) Fan, W.-Q.; Katritzky, A. R. In Comprehensive Heterocyclic
Chemistry II; Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; Elsevier Science:
Oxford, 1996; Vol. 4, pp 1–126; (e) Padwa, A. Angew. Chem., Int. Ed. Engl. 1976,
15, 123–136; (f) Oppolzer, W. Angew. Chem., Int. Ed. 1977, 16, 10–23; (g) Seebach,
D.; Enders, D.; Dach, R.; Pieter, R. Chem. Ber. 1977, 110, 1879–1886; (h) Pearson,
W. H.; Bergmeier, S. C.; Degan, S.; Lin, K.-C.; Poon, Y.-F.; Schkeryantz, J. M.;
Williams, J. P. J. Org. Chem. 1990, 55, 5719–5738; (i) Tezuka, K.; Compain, P.;
Martin, O. R. Synlett 2000, 1837–1839.
6. (a) Huisgen, R.; Mo¨bius, L.; Szeimies, G. Chem. Ber. 1965, 98, 1138–1152;
(b) Jones, H.; Fordice, M. W.; Greenwald, R. B.; Hannah, J.; Jacobs, A.;
Ruyle, W. V.; Walford, G. L.; Shen, T. Y. J. Med. Chem. 1978, 21, 1100–1104.
7. (a) Bastide, J.; Hamelin, J.; Txier, F.; VoQuang, Y. Bull. Soc. Chim. Fr. 1973, 2555–
2579; (b) Fusco, R.; Garanti, L.; Zecchi, G. J. Org. Chem. 1975, 40, 1906–1909;
(c) Tsuge, O.; Ueno, K.; Inabe, A. Heterocycles 1976, 4, 1–7.
8. Garanti, L.; Locatelli, A.; Zecchi, G. J. Heterocycl. Chem. 1976, 13, 657–679.
9. Bertrand, M.; Dulcere, J.-P.; Santelli, M. Tetrahedron Lett. 1977, 18,
1783–1784.
10. Dulcere, J.-P.; Tawil, M.; Santelli, M. J. Org. Chem. 1990, 55, 571–575.
11. (a) Heilbron, I. M.; Jones, E. R. H.; Lacey, R. N.; MeCombie, J. T.; Raphael, R.
J. Chem. Soc. 1945, 77–81; (b) Santelli, M,; Bertrand, M. Bull. Soc. Chim. Fr.
1973, 2331–2335.
12. For reviews of the Morita–Baylis-Hillman reaction, see: (a) Ciganek, E. In Or-
ganic Reactions; Paquette, L. A., Ed.; John Wiley: New York, NY, 1997; Vol. 51,
pp 201–350; (b) Drewes, S. E.; Roos, G. H. P. Tetrahedron 1988, 44, 4653–4670;
(c) Basavaiah, D.; Rao, P. D.; Hyma, R. S. Tetrahedron 1996, 52, 8001–8062; (d)
Langer, P. Angew. Chem., Int. Ed. 2000, 39, 3049–3052; (e) Masson, G.; Hous-
seman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614–4628; (f) Basavaiah, D.;
Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811–891; (g) Basavaiah, D.;
Rao, K. V.; Reddy, R. J. Chem. Soc. Rev. 2007, 36, 1581–1588; (h) Shi, Y.-L.; Shi, M.
Eur. J. Org. Chem. 2007, 2905–2916; (i) Declerck, V.; Martinez, J.; Lamaty, F.
Chem. Rev. 2009, 109, 1–48; (j) Ma, G.-N.; Jiang, J.-J.; Wei, Y. Chem. Commun.
2009, 5496–5514.
4.5.9. 5-Acetyl-3-(4-fluorophenyl)-6H-pyrrolo[1,2-c][1,2,3]triazole
(5i). Yield: 75%; white solid; mp: 154–156 ꢀC; (hexane–EtOAc); IR
(KBr) 1665 cmꢂ1
;
1H NMR (CDCl3)
d
2.54 (s, 3H, CH3), 5.16
(d, J¼1.9 Hz, 2H, CH2), 7.15–7.21 (m, 2H, aromatic), 7.55 (t, J¼1.9 Hz,
1H, CH), 7.85–7.89 (m, 2H, aromatic); 13C NMR (CDCl3)
26.1, 52.0,
d
116.2 (d, J¼22.0 Hz), 126.0, 126.5, 127.7 (d, J¼8.6 Hz), 139.3, 140.0,
146.6, 162.9 (d, J¼249.0 Hz), 192.8; EIMS: m/z (%) 217 (73), 202
(100), 174 (17), 146 (9), 106 (77); HRMS (FABþ): m/z C13H10FN3ONa
[MþNa]þ calcd 266.0707, obsd 266.0705. Anal. Calcd for
C13H10FN3O: C, 64.19; H, 4.14; N, 17.28. Found: C, 64.26; H, 4.20; N,
17.01.
4.5.10. 5-Acetyl-3-(3-methoxyphenyl)-6H-pyrrolo[1,2-c][1,2,3]tri-
azole (5j). Yield: 92%; white solid; mp: 165–157 (hexane–EtOAc); IR
(KBr) 1672 cmꢂ1; 1H NMR (CDCl3)
d 2.54 (s, 3H, CH3), 3.90 (s, 3H, CH3),
5.16 (d, J¼1.9 Hz, 2H, CH2), 6.93–6.97 (m,1H, aromatic), 7.39–7.41 (m,
2H, aromatic), 7.50–7.51 (m, 1H, aromatic), 7.58 (t, J¼1.9 Hz, 1H, CH);
13C NMR (CDCl3)
d 26.2, 51.9, 55.4,111.2,114.5,118.2,126.3,130.1,131.4,
139.7, 140.7, 146.5, 160.1, 193.0; EIMS: m/z (%) 229 (70), 214 (100), 186
(20), 106 (42); HRMS (FABþ): m/z C14H13N3O2Na [MþNa]þ calcd
278.0907, obsd 278.0905. Anal. Calcd for C14H13N3O2: C, 65.87; H,
5.13; N, 16.46. Found: C, 65.63; H, 5.06; N, 16.21.
4.5.11. 5-Acetyl-3-(thiophen-2-yl)-6H-pyrrolo[1,2-c][1,2,3]triazole
(5k). Yield: 80%; white solid; mp: 157–158 ꢀC (hexane–EtOAc); IR
(KBr) 1673 cmꢂ1; 1H NMR (CDCl3)
d
2.54(s, 3H, CH3), 5.15 (d, J¼2.0 Hz,
2H, CH2), 7.14 (dd, J¼5.4 and 3.9 Hz,1H, aromatic), 7.39 (dd, J¼5.4 and
0.9 Hz, 1H, aromatic), 7.48 (dd, J¼3.9 and 0.9 Hz, 1H, aromatic), 7.51
(t, J¼2.0 Hz, 1H, CH); 13C NMR (CDCl3)
d 26.1, 52.1, 124.8, 125.6, 126.0,
128.0, 132.3, 136.2, 138.8, 146.3, 192.9; EIMS: m/z (%) 205 (98), 190
(58), 162 (40), 106 (100); HRMS (FABþ): m/z C11H9N3OSNa [MþNa]þ
calcd 254.0366, obsd 254.0365. Anal. Calcd for C11H9N3OS: C, 57.13; H,
3.92; N, 18.17. Found: C, 56.88; H, 3.81; N, 18.02.
4.5.12. 3-Phenyl-7,8-dihydro-4H-[1,2,3]triazolo[1,5-a]indol-5(6H)-
one (5n). Yield: 85%; light yellow solid; mp: 204–205 ꢀC (hexane–
EtOAc); IR (KBr) 1668, 1635 cmꢂ1 1H NMR (CDCl3)
; d 2.32–2.40
(m, 2H. CH2), 2.61–2.66 (m, 2H, CH2), 3.16–3.22 (m, 2H, CH2), 3.82
(dd, J¼2.7 and 2.5 Hz, 2H, CH2) 7.35–7.51 (m, 3H, aromatic), 7.85–
13. For
a review of heterocycle syntheses using the Morita–Baylis–Hillman
7.88 (m, 2H, aromatic); 13C NMR (CDCl3)
d 21.2, 22.2, 25.7, 37.3,
chemistry, see: Singh, V.; Batra, S. Tetrahedron 2008, 64, 4511–4574.
14. For our recent examples, see: (a) Song, Y. S.; Lee, C. H.; Lee, K.-J. J. Heterocycl.
Chem. 2003, 40, 939–941; (b) Park, J. B.; Ko, S. H.; Kim, B. G.; Hong, W. P.; Lee,
K.-J. Bull. Korean Chem. Soc. 2004, 25, 27–28; (c) Park, J. B.; Ko, S. H.; Hong, W. P.;
Lee, K.-J. Bull. Korean Chem. Soc. 2004, 25, 927–930; (d) Hong, W. P.; Lim, H. N.;
Park, H. W.; Lee, K.-J. Bull. Korean Chem. Soc. 2005, 26, 655–657; (e) Hong, W. P.;
Lee, K.-J. Synthesis 2005, 33–38; (f) Hong, W. P.; Lee, K.-J. Synthesis 2006, 963–
968; (g) Ji, S.-H.; Hong, W. P.; Ko, S. H.; Lee, K.-J. J. Heterocycl. Chem. 2006, 43,
799–801; (h) Yi, H.-W.; Park, H. W.; Song, Y. S.; Lee, K.-J. Synthesis 2006, 1953–
1960; (i) Lim, H.N.; Ji, S.-H.; Lee, K.-J. Synthesis 2007, 2454–2460; (j) Song, Y. S.;
Lee, K.-J. Synthesis 2007, 3037–3043; (k) Lim, H. N.; Song, Y. S.; Lee, K.-J. Syn-
thesis 2007, 3376–3384; (l) Jeon, K. J.; Lee, K.-J. J. Heterocycl. Chem. 2008, 45,
615–619; (m) Ahn, S.-H.; Lim, H. N.; Lee, K.-J. J. Heterocycl. Chem. 2008, 45,
125.6, 128.3, 129.0, 129.2, 129.9, 135.7, 140.6, 152.8, 195.0; EIMS: m/z
(%) 251 (2) [Mþ], 225 (89), 207 (31), 197 (34), 169 (100); HRMS
(FABþ): m/z C15H13N3ONa [MþNa]þ calcd 274.0958, obsd 274.0953.
Anal. Calcd for C15H13N3O: C, 71.70; H, 5.21; N, 16.72. Found: C,
71.56; H, 5.47; N, 16.50.
4.5.13. 3-Pentyl-7,8-dihydro-4H-[1,2,3]triazolo[1,5-a]indol-5(6H)-
one (5o). Yield: 47%; yellow solid; mp: 49–50 ꢀC (hexane–EtOAc);
IR (KBr) 1670, 1634 cmꢂ1
;
1H NMR (CDCl3)
d
0.90 (t, J¼6.1 Hz, 3H,